分子动力学和实验评价的piperine作为一个潜在的mTOR抑制剂在结肠癌细胞的分子动力学和实验评价
Ifat Jan1,2, Tabasum Ali1,2, Rafat Ali3
1Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006 India.
In silico pharmacology
|March 31, 2025
概括
黑胡中的天然化合物皮佩林 (Piperine) 是癌症治疗中的mTOR抑制剂. 在实验室研究中,它有效地降低了结肠癌细胞的活力和迁移.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 皮佩林是一种天然的类化合物,来自黑胡 (Piper nigrum).
- 哺乳动物的目标拉帕米辛 (mTOR) 蛋白质是关键调节剂,与癌症发展有关.
- 针对mTOR是癌症治疗中的重要策略.
研究的目的:
- 为了研究皮佩林作为mTOR蛋白的抑制剂的潜力.
- 为了评估 piperine 对 HCT-116 结肠癌细胞系的抗癌作用.
主要方法:
- 使用分子对接和动态模拟来评估皮佩林与mTOR蛋白的相互作用.
- 在体外测试,包括MTT和伤测试,在HCT-116细胞上进行.
主要成果:
- 皮皮林对mTOR活性部位表现出强烈的结合亲和力,与已知的抑制剂拉巴胺相似.
- 分子动力学模拟证实了piperine与mTOR以ATP竞争的方式稳定结合.
- 皮皮林显著降低了HCT-116结肠癌细胞活力,并抑制了细胞迁移.
结论:
- 皮皮林作为一种mTOR抑制剂具有显著的潜力.
- 这些发现表明,皮佩林可能是开发新型癌症治疗药物的有价值候选者.
- 需要进一步的研究来探索皮佩林在癌症治疗中的治疗应用.
更多相关视频
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K